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The central nervous system is closely linked to the immune system at several levels. The brain parenchyma is separated from
the periphery by the blood brain barrier, which under normal conditions prevents the entry of mediators such as activated
leukocytes, antibodies, complement factors, and cytokines. The myeloid cell lineage plays a crucial role in the development of
immuneresponsesatthecentrallevel,anditcomprisestwomainsubtypes:(1)residentmicroglia,distributedthroughoutthebrain
parenchyma; (2) perivascular macrophages located in the brain capillaries of the basal lamina and the choroid plexus. In addition,
astrocytes, oligodendrocytes, endothelial cells, and, to a lesser extent, neurons are implicated in the immune response in the
central nervous system. By modulating synaptogenesis, microglia are most speciﬁcally involved in restoring neuronal connectivity
following injury. These cells release immune mediators, such as cytokines, that modulate synaptic transmission and that alter the
morphology of dendritic spines during the inﬂammatory process following injury. Thus, the expression and release of immune
mediators in the brain parenchyma are closely linked to plastic morphophysiological changes in neuronal dendritic spines. Based
on these observations, it has been proposed that these immune mediators are also implicated in learning and memory processes.
1.Introduction
Cell survival in the central nervous system (CNS) has been
closely associated with activation of the immune system,
a tightly controlled process [1]. The CNS parenchyma is
separated from the bloodstream by the blood brain barrier
(BBB), the integrity of which is maintained by endothelial
tight junctions. Under normal conditions, the BBB prevents
the entry into the brain parenchyma of leukocytes, antibod-
ies, complement factors, and cytokines, as well as antigen
presenting cells (APCs) such as dendritic cells, B cells, and
macrophages [1, 2].
In the CNS, the immune system mediates several an-
atomical and physiological adaptations to protect its vital
functions from the damage caused by inﬂammation [3]
(Figure 1).InadditiontotheBBBandthecerebrospinalﬂuid
(CSF), which also prevents the entry of plasma protein
and immune cells into the parenchyma [3, 4], other mech-
anisms appear to sustain the “immune privilege” of the
CNS, including local production of anti-inﬂammatory
molecules such as transforming growth factor (TGF-β),
melanocyte-stimulating hormone-alpha (α-MSH), and vas-
oactive intestinal peptide (VIP), as well as the constitutive
expression of the Fas ligand (FasL or CD95L) that mediates
the inﬁltrating immune cells death in the CNS [3, 4].
Studies of CNS damage have predominantly focused on
neurons, as these cells determine the survival and function
of the CNS [5–7]. However, in recent decades, additional cell
subtypes have been seen to be involved in maintaining CNS
homeostasis [7]. Microglial cells can generate an immune
responseafterdamageandalternervecellanddendriticspine
morphophysiology. Similarly, dendritic spines may play a
role in such events, these spines specializing in translating2 Neural Plasticity
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Figure 1: A bidirectional relationship links the immune and nervous systems, which communicate through the synthesis and the
release of mediators such as cytokines, prostanoids, neuropeptides, and neurotransmitters. CRH: corticotropin-releasing hormone. CRF:
corticotropin-releasing factor. ACTH: adrenocorticotropic hormone. NTS: nuclei of the solitary tract. LC: locus coeruleus. SNS: sympathetic
nervous system. PNS: parasympathetic nervous system.
aﬀerent excitatory synaptic inputs to postsynaptic neurons.
Plastic changes in these structures are closely associated
withtheprocessingofcognitive-relatedaﬀerentinformation.
Accordingly, alterations in dendritic spine morphophysi-
ology induced by microglia-associated immune responses
exert deleterious eﬀects on the transmission of mnemonic
information, although the underlying mechanisms remain
poorly understood.
2.ImmuneCells inthe NervousSystem
The monocyte/macrophage cell lineage plays a key role in
the development of innate and adaptive immune responses.
Furthermore, some cell subpopulations associated with this
lineage exhibit highly specialized phagocytic activity follow-
ing cell degradation [8]. Two major subtypes of CD45+ cells
have been described in the myeloid lineage: the microglia
resident population that is distributed throughout the brain
parenchyma; perivascular macrophages located in the brain
capillaries of the basal lamina and the choroid plexus.
Parenchymal microglia cells are precursor cells derived from
CD45+ bone marrow cells that migrate into the CNS in the
early stages of development, and they are capable of self-
renewal within the brain parenchyma [7, 8]. By contrast,
perivascular macrophages replace bone marrow elements at
am o r er a p i dr a t ea n dt h e yh a v em o r ef e a t u r e so fm o n -
ocytes/macrophages than parenchymal microglia [7, 8].
To date, no speciﬁc markers for these cell types have
been described, although perivascular macrophages express
higher levels of CD45, major histocompatibility complex
(MHC-II), costimulatory molecules, and receptor recogni-
tion patterns than CD14 cells. The levels of these media-
tors are slightly lower in parenchymal microglial cells [8]
(Figure 2).
Glial cells are the main source of many of the resident
cytokines in the CNS. In addition to being “target” cells
for cytokines, glial cells release important amounts of
neuroactive substances that promote neuronal survival, such
as neurotrophins and growth factors. By contrast, microglia
release potentially neurotoxic substances, including nitric
oxide (NO), reactive oxygen species (ROS), proteases, exci-
tatory amino acids, and cytokines [9].
Activated macrophages (MQs) and microglia represent a
major source of proinﬂammatory cytokines and chemokines
within the CNS. These cells release reactive nitrogen species
(RNS) and ROS and produce several factors that exert cyto-
toxic eﬀects on oligodendrocytes and neurons [7]. Activated
microglia can provoke excess MHC-II expression, facilitatingNeural Plasticity 3
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Figure 2: Microglia are activated in the brain parenchyma and mediate the synthesis and release of proinﬂammatory and anti-inﬂammatory
cytokines, prostanoids, complement system molecules, and free radicals such as nitric oxide, aﬀecting other cells including astrocytes,
oligodendrocytes, and neurons. The signal established between microglial cells and neurons through the expression of CD200-CD200R
maintains the microglia in a nonactivated state, and, when this signal is interrupted, microglia are immediately activated and initiate the
generation and release of inﬂammatory mediators. PGE2: prostaglandin-E2; IFN-R: interferon-receptor; TNF-α: tumor necrosis factor-
alpha; TNFR: tumor necrosis factor receptor; IL-1β: interleukin-1 beta; IL-6: interleukin-6; IL-10: interleukin-10; IL-4: interleukin-4; NGF:
nerve growth factor.
its involvement in events mediated by the immune sys-
tem. Microglial activation strongly inﬂuences the proﬁle of
cytokines released by these cells through two distinct mecha-
nisms: pattern recognition receptors (PRRs; molecular traces
remaining after a pathogenic insult) and immune response
activation [6]. Activation of the monocyte/macrophage cell
lineagethroughPRRsrepresentsanimportantcomponentof
the innate immune response, which induces the production
of proinﬂammatory cytokines and chemokines like IL-8,
monocyte chemoattractant protein-1 (MCP-1), macrophage
inﬂammatory protein-1 (MIP-1α), and MIP-1β.M o r e o v e r ,
other forms of PRR can activate regulatory cytokines within
theCNS,suchasinterleukin-4 (IL-4)andinterleukin-10(IL-
10) [6, 7].
Microglia located in perivascular areas can act as antigen
presenting cells (APCs.) These cells evolve from their resting
state and release signiﬁcant quantities of Th1 cytokines,
such as tumor necrosis factor-alpha (TNF-α) and IL-12
[7]. Such perivascular microglia alerts the parenchymal mi-
croglia to the signals of “damage,” indicating the presence of
inﬂammatory cells in the perivascular space. This provokes
the activation of the parenchymal microglia, which prolif-
erate and produce eﬀector cells that eliminate these damage
signals and that restore the tissue integrity [7]. Microglia can
exhibit diverse activation states, including migratory, phago-
cytic, and regenerative. These diﬀerent functional states are
regulated by positive and negative feedback loops and by
microenvironment damage signals [7]. Activated microglia
in turn activate several proinﬂammatory cytokines, anti-
inﬂammatory cytokines (IL-10, TGF-β, IL-1Ra), prostanoids
(prostaglandin-E2 or PGE2, prostaglandin-D2 or PGD2 and
thromboxane-A2 or TXA2), cytotoxic molecules (ROS, RNS,
inducible nitric oxide synthase or iNOS), and chemokines
(IL-8, IL-10, MCP-1, MIP-1α,M I P - 1 β,M I P - 3 β,M D C ,
RANTES) [5, 10, 11].
The contribution of astrocytes to the neuroimmune sys-
tem is even more complex than that of microglia. This
population plays an essential role in neuronal life-support,
and it is essentially divided into 2 main subtypes: ﬁ-
brous astrocytes located in the white matter; protoplasmic4 Neural Plasticity
astrocytes located in the gray matter, and they contribute to
the BBB [9, 12, 13]. Some of the most important functions
of astrocytes are related to the regulation of ion transport
and neurotransmitter concentrations and the transmission
of electric impulses. Astrocytes also act as neuroprotectors
by secreting neurotrophins and releasing potentially toxic
inﬂammatory molecules [9]( Figure 2). The third type of
glial cells is the oligodendrocyte, which participates actively
inmyelinationandisalsoinvolvedinthesecretionofspeciﬁc
inﬂammatory molecules [7]( Figure 2).
The microvasculature is a key element in cerebral dam-
age. Endothelial cells represent an important source of
immune mediators such as prostanoids and nitric oxide,
both of which are implicated in the immune cell adhe-
sion process [9]. Damage to the BBB can result in in-
creased permeability, facilitating leukocyte access to the
cerebral parenchyma, inducing the release of neurotoxins
and endogenous inﬂammatory mediators and promoting
phagocytosis of cell debris by perivascular MQs [9].
Diseases of the nervous system result in the upregulation
of MHC-II and adhesion-costimulation molecules (CD11a,
CD40, CD54, CD80, CD86) in activated microglia, indicat-
ing that these cells may acquire APC activity and actively
participate in T-cell restimulation [14, 15]. This suggests
the existence of a complex interaction network linking
microglia, astrocytes, and invader T cells and involving a
balancebetween Th1/Th2 signals, whichdeﬁnes theimmune
response of the CNS [14, 16].
In vivo microglial activation is regulated by several
neuron-derived molecules, such as the CD200 marker, whilst
microglia expresses CD200R. When CD200 expression is
suppressed as a result of cell damage or after pathogenic
stimulus, microglia switch to an activated phenotype, induc-
ing the expression of the CD45 receptor, MHC-II, and the
complement receptor 3 [17]. Resident microglia perform a
wide variety of highly specialized functions in the cerebral
parenchyma. These include the modulation of synaptic
strength and eﬃcacy through the remodeling of synaptic
architecture [10] and induction of new synapses through
regulation of synaptogenesis at the early stages of brain de-
velopment. Microglia have also been suggested to regulate
secretion of thrombospondin by astrocytes and secretion of
the T-cell-derived serine protease (TSP-1). TSP-1 interacts
with integrins that are associated with the CD47 protein
and with the regulatory protein SRIPa, a transmembrane
protein expressed in neurons and macrophages. The SRIPa-
CD47 system regulates migration, phagocytosis, immune
homeostasis, and the maintenance of the neuronal network
[10].
Microglia play a key role in restoring neuronal connec-
tivity following damage, by controlling reactive synaptoge-
nesis [10]. Microglial cells may inﬂuence the homeostatic
process of “synaptic scaling” that provides the adjustment
in the strength of all synapses through distinct mechanisms
in response to long-lasting changes in neuronal activity
[10]. In addition, microglia are intimately involved in the
development of the nervous system and in controlling
the balance between neurogenesis and neuronal death. As
mentioned previously, these cells play a dual role being
implicated both in neurogenesis and neuronal death. While
the mechanisms underlying this dichotomy remain unclear,
diﬀerences in the activation state of microglia [10, 18]a n d
the diﬀerential release of cytotoxic or cyto protective factors
[18] have been reported. Thus, we conclude that microglia
have the potential to regulate the development and function
of neuronal networks by constantly monitoring the “status”
of synaptic contacts and integrating new information [10].
3 .T h eR el a ti o n s h i pbet w ee nt h eI m m u n e
System andDendriticSpines
TheinﬂammatoryprocessobservedintheCNSduringeither
sepsisorendotoxicshockinvolvesawidevarietyofmolecules
that regulate the synthesis and release of inﬂammatory
mediators, such as proinﬂammatory cytokines, prostanoids,
and cytotoxic molecules. Such events are triggered both in
the peripheral and the central nervous systems. These medi-
ators are also generated and released during excitotoxicity
inducedbyexcessiveglutamaterelease,ischemiareperfusion,
brain trauma and neurodegenerative processes such as
those associated with multiple sclerosis, Alzheimer’s and
Parkinson’s diseases, leading to the activation of common
inﬂammatory pathways [15–17, 19]. One such mediator
is TNF-α, which is released by nerve cells and modiﬁes
the ﬁring rate and excitability of neurons, thereby aﬀecting
processes such as long-term potentiation (LTP) and long-
term depression (LTD) [15–17, 19].
The complex neural networks in the mammalian fore-
brain are regulated by interactions with glia cells (Figure 3),
but the underlying mechanisms are poorly understood.
Microglia may induce synaptic remodeling though direct
contact or via the release of soluble factors (cytokines)
that destabilize nearby synapses [19]. Microglia are thought
to directly modulate dendritic spine dynamics in response
to lipopolysaccharide (LPS) administration [19], which in
mice results in a signiﬁcant long-term upregulation of the
expression of genes involved in the release and metabolism
of arachidonic acid (AA) in the hippocampus [20, 21].
AA is a precursor of prostaglandins, thromboxanes, and
leukotrienes, biochemical mediators of the inﬂammatory
process responsible for endotoxic shock [20]. At a dose
of 1mg/kg body weight, intraperitoneal administered LPS
to rats and mice induces “sickness behavior,” changes in
temperature and oxidative stress in the brain [20, 22,
23]. Likewise, acute peripheral administration of LPS is
suﬃcienttotriggermicroglialactivation,inducingtherelease
of proinﬂammatory cytokines at both the peripheral and
central levels [19, 24].
Ar e c e n ts t u d yr e p o r t e da l t e r e dc o g n i t i v ep r o c e s s e si n
a group of patients recovering from sepsis and endotoxic
shock, including deﬁcits in memory and attention [19].
LPS interacts with toll-like receptors (TLRs) at the MQs
level, triggering the generation and release of a variety
of important proinﬂammatory cytokines, including TNF-
α,I L - 1 β, and IL-6. These proteins can cross the BBB to
activate both microglia and astrocytes near brain capillaries.
In addition, TNF-α,I L - 1 β, and IL-6 promote informationNeural Plasticity 5
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Figure 3: Interleukin-2 is involved in developmental processes such as neuronal dendritic arborization, and it induces a signiﬁcant increase
in spinogenesis and dendritic ﬁlopodia motility. Activated microglia release signiﬁcant amounts of inﬂammatory mediators that induce
neuronal death, synapse remodeling, and destabilization of synaptic contacts. IL-2: interleukin-2; TNF-α: tumor necrosis factor-alpha; IL-
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ﬂow via the vagus nerve, through the so-called inﬂammatory
reﬂex. These responses promote the synthesis of PGs and
cytokines in the brain parenchyma, which induce a fever
state and sickness behavior [19]. Peripheral administration
of LPS in rodents can aﬀect certain cognitive functions by
impairing LTP, a key physiological process in learning and
spatial memory. LPS administration also induces peripheral
inﬂammation, aﬀecting the function of neural networks and
glial cells. In addition, resident microglial cells in the brain
parenchyma are activated, altering their phenotype and in
turn aﬀecting synaptic function [19].
One week after LPS administration, the dynamics of
dendritic spines are comparable to those of control animals,
indicating a minimal eﬀect of acute systemic LPS treatment,
at least in the short term. However, by 4 weeks after LPS
administration, dendritic spine density increases to twice
that of control animals. Moreover, this increase in spine
densityisassociatedwithmicroglialactivity,suggestinglong-
term eﬀects on the CNS triggered by a transient peripheral
immune response [19].
Acute induction of sickness behavior, which is accom-
panied by adverse eﬀects on both emotional and cognitive
processes, is at least partially responsible for the altered
morphophysiological dynamics of dendritic spines [19, 24].
Cytokines released from glial cells can aﬀect synaptic func-
tion, leading to alterations in spine morphology. Microglial
cell proliferation has been reported in animal models of neu-
rodegenerative disorders, accompanied by increased levels
of proinﬂammatory cytokines and alterations in dendritic
spine morphology and density [19]. Recent studies also
suggest that the creation of an “inﬂammatory environment”
may inﬂuence the generation of new synaptic connections.
Indeed, microglia activated by inﬂammation may release cy-
tokines and growth factors that “modulate” synaptic trans-
mission, possibly by altering dendritic spine morphology.
The inﬂammatory process also regulates functional synaptic
connectivity, generating new connections in the adult brain
[24].
Interestingly, new hippocampal neurons grown under
conditions of chronic inﬂammation are more responsive
to inhibitory aﬀerent signals than those grown in normal
conditions prior to the onset of inﬂammation. In the latter
case, inﬂammation has no eﬀect on the cell migration or
polarity, on dendritic arborization or development, or on
spine density, although dendritic spines in the new granule
cells of the dentate gyrus exhibit very high mobility [24–26].
IL-2 is an immunoregulatory cytokine released from
neurons and astrocytes in the CNS upon T-cell activation.
This cytokine binds to receptors that are widely distributed
throughout the brain. Following its release, IL-2 is thought
to exert neuroregulatory eﬀects and is implicated in various
CNSdisorders.Inthehippocampusofexperimentalanimals,6 Neural Plasticity
IL-2 inﬂuences several cognitive processes, such as LTP,
modifying the molecular substrates underlying learning and
memory. In addition, IL-2 provides trophic support to
rat hippocampal neurons in primary culture, with positive
eﬀects on morphology and neurite branching [25]. In
cultured hippocampal neurons, IL-2 also aﬀects dendritic
development and spinogenesis by day 14 in vitro, increasing
dendritic arborization and neuronal growth. These eﬀects
are more pronounced on day 7, when the cytokine signiﬁ-
cantlyaugmentsthemotilityofdendriticﬁlopodia.Together,
these ﬁndings suggest that IL-2 exerts promoter-like eﬀects
on dendritic development and spinogenesis in cultured hip-
pocampal neurons at early developmental stages [25].
The hippocampal region is a very plastic structure, dis-
playing ﬂuctuations in dendritic arborization, as well as
changes in dendritic spine density and neuronal cell body
size. These and other plastic modiﬁcations of neuronal
cytoarchitecture are heavily implicated in hippocampal-
dependent learning and memory processes. Many regulatory
and stress factors can aﬀect neuronal circuitry and interfere
with the development of dendritic trees. In this context, IL-
2 increases the number and length of dendritic branches
in neuronal primary culture on days 7, 10, and 14 in vitro
[25]. The length, diameter, and arborization of dendritic
trees signiﬁcantly inﬂuence neuronal function, and, hence,
by increasing dendritic arborization and length, the signal
transmission between neurons and the function of local neu-
ronal networks are modulated. Accordingly, such alterations
are associated with the development of behavioral disorders
[25].
The formation of ﬁlopodia is a highly dynamic process
that occurs early in CNS development in mammals. These
structures may be involved in the formation of new dendritic
spines and synapses at later stages of development. The
ability of IL-2 to increase ﬁlopodia motility is likely involved
in the development of new dendrites [25, 27].
4. Conclusion
In conclusion, we propose a close relationship between
cytokine expression and the regulation of dendritic spine
dynamics within a microuniverse in which the immune
system and nervous system are closely linked. These inter-
nal interdependent systems mediate nonspeciﬁc behavioral
responses, as well as learning and memory processes. Further
studies are required to fully determine the full nature and
physiological outcome of the relationship between immune
system activity and dendritic spine dynamics, as well as the
potential implications for learning and memory processes.
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